126 related articles for article (PubMed ID: 1315399)
1. Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man.
Hishikawa K; Nakaki T; Tsuda M; Esumi H; Ohshima H; Suzuki H; Saruta T; Kato R
Jpn Heart J; 1992 Jan; 33(1):41-8. PubMed ID: 1315399
[TBL] [Abstract][Full Text] [Related]
2. L-arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans.
Kanno K; Hirata Y; Emori T; Ohta K; Eguchi S; Imai T; Marumo F
Clin Exp Pharmacol Physiol; 1992 Sep; 19(9):619-25. PubMed ID: 1327594
[TBL] [Abstract][Full Text] [Related]
3. Role of L-arginine-nitric oxide pathway in hypertension.
Hishikawa K; Nakaki T; Suzuki H; Kato R; Saruta T
J Hypertens; 1993 Jun; 11(6):639-45. PubMed ID: 8397243
[TBL] [Abstract][Full Text] [Related]
4. L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship.
Bode-Böger SM; Böger RH; Galland A; Tsikas D; Frölich JC
Br J Clin Pharmacol; 1998 Nov; 46(5):489-97. PubMed ID: 9833603
[TBL] [Abstract][Full Text] [Related]
5. [The effect of NG-nitro-L-arginine administration on the hemodynamics and plasma hormone levels during endotoxin shock in dogs].
Takekoshi K; Kasai K; Nakamura T
Nihon Naibunpi Gakkai Zasshi; 1993 Mar; 69(3):135-48. PubMed ID: 8385633
[TBL] [Abstract][Full Text] [Related]
6. Haemodynamic and biochemical responses to L-arginine and L-lysine infusions in normal subjects: L-arginine-induced vasodilatation cannot be explained by non-specific effects of cationic amino acids.
Smulders RA; Aarsen M; Teerlink T; De Vries PM; Van Kamp GJ; Donker AJ; Stehouwer CD
Clin Sci (Lond); 1997 Apr; 92(4):367-74. PubMed ID: 9176035
[TBL] [Abstract][Full Text] [Related]
7. L-arginine infusion has no effect on systemic haemodynamics in normal volunteers, or systemic and pulmonary haemodynamics in patients with elevated pulmonary vascular resistance.
Baudouin SV; Bath P; Martin JF; Du Bois R; Evans TW
Br J Clin Pharmacol; 1993 Jul; 36(1):45-9. PubMed ID: 8396955
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide in streptozotocin-induced diabetes mellitus in rats.
Maree A; Peer G; Iaina A; Blum M; Wollman Y; Csernihovsky T; Silverberg DS; Cabili S
Clin Sci (Lond); 1996 May; 90(5):379-84. PubMed ID: 8665775
[TBL] [Abstract][Full Text] [Related]
9. L-arginine partially reverses established adrenocorticotrophin-induced hypertension and nitric oxide deficiency in the rat.
Wen C; Li M; Fraser T; Wang J; Turner SW; Whitworth JA
Blood Press; 2000; 9(5):298-304. PubMed ID: 11193135
[TBL] [Abstract][Full Text] [Related]
10. L-arginine does not improve biochemical and hormonal response in trained runners after 4 weeks of supplementation.
Alvares TS; Conte-Junior CA; Silva JT; Paschoalin VM
Nutr Res; 2014 Jan; 34(1):31-9. PubMed ID: 24418244
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans.
Mayer BX; Mensik C; Krishnaswami S; Derendorf H; Eichler HG; Schmetterer L; Wolzt M
Br J Clin Pharmacol; 1999 May; 47(5):539-44. PubMed ID: 10336578
[TBL] [Abstract][Full Text] [Related]
12. L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects.
Bode-Böger SM; Böger RH; Creutzig A; Tsikas D; Gutzki FM; Alexander K; Frölich JC
Clin Sci (Lond); 1994 Sep; 87(3):303-10. PubMed ID: 7955906
[TBL] [Abstract][Full Text] [Related]
13. Response of nitric oxide pathway to L-arginine infusion at the altitude of 4,350 m.
Schneider JC; Blazy I; Déchaux M; Rabier D; Mason NP; Richalet JP
Eur Respir J; 2001 Aug; 18(2):286-92. PubMed ID: 11529286
[TBL] [Abstract][Full Text] [Related]
14. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.
Bech JN; Nielsen CB; Pedersen EB
Am J Physiol; 1996 May; 270(5 Pt 2):F845-51. PubMed ID: 8928847
[TBL] [Abstract][Full Text] [Related]
15. Effects of L-arginine infusion on renal hemodynamics in patients with mild essential hypertension.
Higashi Y; Oshima T; Ozono R; Watanabe M; Matsuura H; Kajiyama G
Hypertension; 1995 Apr; 25(4 Pt 2):898-902. PubMed ID: 7721451
[TBL] [Abstract][Full Text] [Related]
16. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
[TBL] [Abstract][Full Text] [Related]
17. Acute effect of nitric oxide supplement on blood nitrate/nitrite and hemodynamic variables in resistance trained men.
Bloomer RJ; Williams SA; Canale RE; Farney TM; Kabir MM
J Strength Cond Res; 2010 Oct; 24(10):2587-92. PubMed ID: 20885188
[TBL] [Abstract][Full Text] [Related]
18. L-arginine as an antihypertensive agent.
Hishikawa K; Nakaki T; Suzuki H; Kato R; Saruta T
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S196-7. PubMed ID: 1282968
[TBL] [Abstract][Full Text] [Related]
19. Effects of 7 days of arginine-alpha-ketoglutarate supplementation on blood flow, plasma L-arginine, nitric oxide metabolites, and asymmetric dimethyl arginine after resistance exercise.
Willoughby DS; Boucher T; Reid J; Skelton G; Clark M
Int J Sport Nutr Exerc Metab; 2011 Aug; 21(4):291-9. PubMed ID: 21813912
[TBL] [Abstract][Full Text] [Related]
20. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway.
Vegh A; Szekeres L; Parratt J
Br J Pharmacol; 1992 Nov; 107(3):648-52. PubMed ID: 1472963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
